US Patent Issued to Entrada Therapeutics on Sept. 22 for "Compositions for delivery of antisense compounds" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,989, issued on Sept. 22, was assigned to Entrada Therapeutics Inc. (Boston).

"Compositions for delivery of antisense compounds" was invented by Ziqing Qian (Wellesley, Mass.), Xiang Li (Belmont, Mass.), Mahboubeh Kheirabadi (Natick, Mass.), Mohanraj Dhanabal (Boston), Haoming Liu (Canton, Mass.), Xiulong Shen (Waltham, Mass.), Kimberli Kamer (Boston) and Natarajan Sethuraman (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds comprising cyclic cell penetrating peptides and antisense compounds. Also provided herein are methods of modulating splicing, inhibiting or regulating translation, mediating degradation, blocki...